全文获取类型
收费全文 | 24641篇 |
免费 | 1843篇 |
国内免费 | 1000篇 |
专业分类
耳鼻咽喉 | 633篇 |
儿科学 | 391篇 |
妇产科学 | 268篇 |
基础医学 | 3019篇 |
口腔科学 | 826篇 |
临床医学 | 1740篇 |
内科学 | 2625篇 |
皮肤病学 | 405篇 |
神经病学 | 1294篇 |
特种医学 | 500篇 |
外国民族医学 | 2篇 |
外科学 | 2210篇 |
综合类 | 3812篇 |
现状与发展 | 2篇 |
预防医学 | 1000篇 |
眼科学 | 1916篇 |
药学 | 4181篇 |
10篇 | |
中国医学 | 1986篇 |
肿瘤学 | 664篇 |
出版年
2024年 | 33篇 |
2023年 | 308篇 |
2022年 | 410篇 |
2021年 | 805篇 |
2020年 | 677篇 |
2019年 | 627篇 |
2018年 | 667篇 |
2017年 | 665篇 |
2016年 | 686篇 |
2015年 | 763篇 |
2014年 | 1276篇 |
2013年 | 1501篇 |
2012年 | 1363篇 |
2011年 | 1410篇 |
2010年 | 1290篇 |
2009年 | 1159篇 |
2008年 | 1182篇 |
2007年 | 1225篇 |
2006年 | 1160篇 |
2005年 | 1100篇 |
2004年 | 926篇 |
2003年 | 847篇 |
2002年 | 729篇 |
2001年 | 667篇 |
2000年 | 524篇 |
1999年 | 516篇 |
1998年 | 443篇 |
1997年 | 398篇 |
1996年 | 338篇 |
1995年 | 356篇 |
1994年 | 324篇 |
1993年 | 247篇 |
1992年 | 282篇 |
1991年 | 239篇 |
1990年 | 223篇 |
1989年 | 218篇 |
1988年 | 197篇 |
1987年 | 178篇 |
1986年 | 159篇 |
1985年 | 232篇 |
1984年 | 195篇 |
1983年 | 140篇 |
1982年 | 189篇 |
1981年 | 143篇 |
1980年 | 126篇 |
1979年 | 88篇 |
1978年 | 76篇 |
1977年 | 62篇 |
1976年 | 42篇 |
1975年 | 21篇 |
排序方式: 共有10000条查询结果,搜索用时 93 毫秒
1.
2.
3.
《American journal of surgery》2023,225(1):113-117
BackgroundRacial disparities in extracorporeal membrane oxygenation (ECMO) outcomes in patients with a broad set of indications are not well documented.MethodsAdults requiring ECMO were identified in the 2016–2019 National Inpatient Sample. Patient and hospital characteristics, including mortality, clinical outcomes, and resource utilization were analyzed using multivariable regressions.ResultsOf 43,190 adult ECMO patients, 67.8% were classified as White, 18.1% Black, and 10.4% Hispanic. Although mortality for Whites declined from 47.5 to 41.0% (P = 0.002), it remained steady for others. Compared to White, Asian/Pacific Islander (PI) race was linked to increased odds of mortalty (AOR = 1.4, 95% CI = 1.1–2.0). Black race was associated with increased odds of acute kidney injury (AOR = 1.4, 95%-CI: 1.2–1.7), while Hispanic race was linked to neurologic complications (AOR 21.6; 95% CI 1.2–2.3). Black and Hispanic race were also associated with increased incremental costs.ConclusionsRace-based disparities in ECMO outcomes persist in the United States. Further work should aim to understand and mitigate the underlying reasons for such findings. 相似文献
4.
《Drug discovery today》2022,27(6):1733-1742
Compounds that exhibit assay interference or undesirable mechanisms of bioactivity are routinely encountered in assays at various stages of drug discovery. We observed that assays for the investigation of thiol-reactive and redox-active compounds have not been collected in a comprehensive review. Here, we review these assays and subject them to experimental optimization to improve their reliability. We demonstrate the usefulness of our assay cascade by assaying a library of bioactive compounds, chemical probes, and a set of approved drugs. These high-throughput assays should complement the array of wet-lab and in silico assays during the initial stages of hit discovery campaigns to pursue only hit compounds with tractable mechanisms of action. 相似文献
5.
《Journal of vascular and interventional radiology : JVIR》2022,33(5):518-524.e3
PurposeTo compare the characteristics of polidocanol (POL) and ethanolamine oleate (EO) sclerosing foams produced by a Shirasu porous glass membrane (SPGM) device with those made using a 3-way stopcock (3WSC).Materials and MethodsFoam half-life times were measured in an ex-vivo benchtop study. Computed tomography (CT) images of each foam were obtained over the time course, and a CT texture analysis was conducted. The bubble size in each foam was measured by an optical microscope.ResultsMedian foam half-life times were longer in the SPGM group than in the 3WSC group (POL: 198 vs 166 s, P = .02; EO: 640 vs 391 s, P < .01). In the CT texture analysis, median standard deviation (SD) and entropy (randomness) were lower, and median energy (uniformity) and gray-level cooccurrence matrix (GLCM) homogeneity were higher in the SPGM group than in the 3WSC group (POL SD: at 30 s and 50–300 s; POL entropy: at 0–60 s; EO SD: at 0–600 s; EO entropy: at 0–460 s; POL energy: at 0–40 s; POL GLCM homogeneity: at 0–250 s; EO energy: at 0–360 s; EO GLCM homogeneity: at 0–480 s; all P < .05). Median bubble diameters in the SPGM group and in the 3WSC group were 69 and 83 μm (P < .01), respectively, in the POL foam; and 36 and 36 μm (P = .45), respectively, in the EO foam.ConclusionsPOL and EO foams had greater uniformity and longer foam half-life time when prepared with an SPGM device than with a 3WSC. 相似文献
6.
7.
8.
《Seminars in perinatology》2022,46(3):151526
Perinatal palliative care has grown out of both an historical necessity in attending to babies in the NICU that face difficult odds of survival, the increasing technology that may avail life-extending, yet technology-dependent, care, and the growth of fetal diagnostic and treatment centers. This review looks ta the history and ethical rationale for making available services from Pediatric and Perinatal Palliative Care to families in the prenatal and postnatal periods caring for a loved one with life-limiting circumstances. 相似文献
9.
10.
Neonates with progressive respiratory failure should be referred early for subspecialty evaluation and lung transplantation consideration. ECMO should be considered for patients with severe cardiopulmonary dysfunction and a high likelihood of death while on maximal medical therapy, either in the setting of reversible medical conditions or while awaiting lung transplantation. While ECMO offers hope to neonates that experience clinical deterioration while awaiting transplant, the risks and benefits of this intervention should be considered on an individual basis. Owing to the small number of infant lung transplants performed yearly, large studies examining the outcomes of various bridging techniques in this age group do not exist. Multiple single-centre experiences of transplanted neonates have been described and currently serve as guidance for transplant teams. Future investigation of outcomes specific to neonatal transplant recipients bridged with advanced devices is needed. 相似文献